# AimMax Therapeutics, Inc. — Form D

AimMax Therapeutics, Inc. of CHAPEL HILL, NC, a company, filed a Form D exempt-offering notice with the SEC on 2017-04-17. The offering totals $200K, of which $200K was reported sold. Industry: Other.

## Offering

- Filed: 2017-04-17
- Form: D
- Accession: 0001701803-17-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $200K
- Amount sold: $200K
- Investors: 1
- Date of first sale: 2017-04-14
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-284929

## Issuer

- Name: AimMax Therapeutics, Inc.
- CIK: 0001701803
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 512 BOOTH ROAD, CHAPEL HILL, NC, 27516
- Phone: 919-968-4500

## Officers, directors & promoters (2)

| Name | Role | Location |
| --- | --- | --- |
| Laurene Wang | Director | Chapel Hill, NC |
| Laurene Wang | Executive Officer | Chapel Hill, NC |

## More

- [CIK 1701803 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1701803&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001701803-17-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.
